38 related articles for article (PubMed ID: 11995803)
1. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in estrogen-deficient mice of healthy background.
Ishimaru N; Arakaki R; Watanabe M; Kobayashi M; Miyazaki K; Hayashi Y
Am J Pathol; 2003 Oct; 163(4):1481-90. PubMed ID: 14507655
[TBL] [Abstract][Full Text] [Related]
2. Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha.
McArthur C; Wang Y; Veno P; Zhang J; Fiorella R
Arch Oral Biol; 2002 Jun; 47(6):443-8. PubMed ID: 12102760
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificity.
Maruyama T; Saito I; Hayashi Y; Kompfner E; Fox RI; Burton DR; Ditzel HJ
Am J Pathol; 2004 Jul; 165(1):53-61. PubMed ID: 15215161
[TBL] [Abstract][Full Text] [Related]
4. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
[TBL] [Abstract][Full Text] [Related]
5. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.
Haneji N; Nakamura T; Takio K; Yanagi K; Higashiyama H; Saito I; Noji S; Sugino H; Hayashi Y
Science; 1997 Apr; 276(5312):604-7. PubMed ID: 9110981
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome.
Inoue H; Tsubota K; Ono M; Kizu Y; Mizuno F; Takada K; Yamada K; Yanagi K; Hayashi Y; Saito I
J Immunol; 2001 May; 166(9):5801-9. PubMed ID: 11313424
[TBL] [Abstract][Full Text] [Related]
7. Autoantigens and Sjögren syndrome.
Toda I
Cornea; 2002 Mar; 21(2 Suppl 1):S13-6. PubMed ID: 11995803
[TBL] [Abstract][Full Text] [Related]
8. The role of caspase cascade on the development of primary Sjögren's syndrome.
Hayashi Y; Arakaki R; Ishimaru N
J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic markers of Sjögren's syndrome.
Witte T
Dev Ophthalmol; 2010; 45():123-128. PubMed ID: 20502032
[TBL] [Abstract][Full Text] [Related]
10. Involvement of apoptotic protease cascade for tissue destruction in Sjögren's syndrome.
Hayashi Y; Yayagi K; Haneji N
Arch Immunol Ther Exp (Warsz); 2000; 48(5):399-403. PubMed ID: 11140467
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against alpha-fodrin in Sjögren's syndrome.
Ulbricht KU; Schmidt RE; Witte T
Autoimmun Rev; 2003 Mar; 2(2):109-13. PubMed ID: 12848967
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune response and target autoantigens in Sjogren's syndrome.
Routsias JG; Tzioufas AG
Eur J Clin Invest; 2010 Nov; 40(11):1026-36. PubMed ID: 20629708
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
